Show simple item record

dc.contributor.authorSerdengecti, K
dc.contributor.authorUzun, H
dc.contributor.authorAydin, S
dc.contributor.authorSoysal, T
dc.contributor.authorOzaras, R
dc.contributor.authorAltiparmak, MR
dc.contributor.authorAtaman, R
dc.contributor.authorTahan, V
dc.date.accessioned2021-03-05T14:41:25Z
dc.date.available2021-03-05T14:41:25Z
dc.date.issued2002
dc.identifier.citationAltiparmak M., Ataman R., Ozaras R., Tahan V., Aydin S., Uzun H., Serdengecti K., Soysal T., "Relative erythrocytosis of patients with end stage renal failure undergoing CAPD", RENAL FAILURE, cilt.24, ss.29-35, 2002
dc.identifier.issn0886-022X
dc.identifier.otherav_b85e9bec-7e28-429e-ad58-7db7bc3e8df3
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/122682
dc.identifier.urihttps://doi.org/10.1081/jdi-120002658
dc.description.abstractBackground and Aim: Although the majority of patients with end stage renal failure have anemia, some have relative erythrocytosis. Patients treated with continuous ambulatory peritoneal dialysis (CAPD) having relative erythrocytosis were studied in order to determine the factors that would be responsible. Methods: Nine out of 89 CAPD patients (10%) were identified as having relative erythrocytosis. Age-, sex- and duration of disease-matched eight patients undergoing CAPD were taken as control. Beside factors of etiologies of renal failure, smoking, renal cysts, viral hepatitides, residual renal function, the adequacy of CAPD. nutritional status. hypertension., serum levels of erythropoietin, IL-1, IL-6, TNF-, and IGF-1 levels were also investigated. Results: Relative erythrocytosis occurred most often in diabetic and amyloidosis patients. None of the parameters studied were found to be significantly different between groups. During 2-year follow-up, although statistically non-significant, patients having relative erythrocytosis seemed to have higher mortality rate due to vascular complications. Conclusion: No single factor seemed to explain erythrocytosis in patients undergoing CAPD, Being diabetic or with amyloidosis may increase the risk.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectNefroloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.titleRelative erythrocytosis of patients with end stage renal failure undergoing CAPD
dc.typeMakale
dc.relation.journalRENAL FAILURE
dc.contributor.department, ,
dc.identifier.volume24
dc.identifier.issue1
dc.identifier.startpage29
dc.identifier.endpage35
dc.contributor.firstauthorID19279


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record